Sakurai T, Ohno N, Yadomae T
Laboratory of Immunopharmacology of Microbial Products, Tokyo College of Pharmacy, Japan.
Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2120-4. doi: 10.1248/cpb.40.2120.
Effect of intravenously (i.v.) or intraperitoneally (i.p.) administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the murine peritoneal macrophage (PM) functions were examined. A single i.v. administration of SSG increased the number of PMs at a dose of 250 micrograms/mouse, and the peak appeared 4 d after administration. However, no special change was observed on peritoneal exude cell (PEC) populations. These PMs showed augmented lysosomal enzyme activity and the peaks appeared in 2 phases, on days 2 and 10. In contrast, SSG administered i.p. (250 micrograms/mouse) increased the number of PMs and enhanced the lysosomal enzyme activity of PMs from day 4, and a broad peak appeared until days 8--12. The populations of PECs were also changed by i.p. injection of SSG. Additionally, SSG administered i.v. enhanced phagocytic activity, H2O2 production and interleukin 1 (IL-1) production, and the kinetics of the activation differed depending on the activities. These data suggest that the effects of SSG on macrophage functions are different depending on administration routes, and there are some different mechanisms in the activation of macrophages in vivo by SSG.
研究了从核盘菌IFO 9395获得的静脉内(i.v.)或腹腔内(i.p.)给予的(1→3)-β-D-葡聚糖SSG对小鼠腹腔巨噬细胞(PM)功能的影响。静脉内单次给予SSG,剂量为250微克/小鼠时可增加PM的数量,给药后4天出现峰值。然而,腹膜渗出细胞(PEC)群体未观察到特殊变化。这些PM显示溶酶体酶活性增强,且在第2天和第10天出现两个峰值阶段。相比之下,腹腔内给予SSG(250微克/小鼠)从第4天起增加了PM的数量并增强了PM的溶酶体酶活性,直到第8至12天出现一个宽峰。腹腔内注射SSG也改变了PEC的群体。此外,静脉内给予SSG增强了吞噬活性、H2O2产生和白细胞介素1(IL-1)产生,并且激活的动力学根据活性而有所不同。这些数据表明,SSG对巨噬细胞功能的影响因给药途径而异,并且SSG在体内激活巨噬细胞存在一些不同的机制。